Page last updated: 2024-09-03

umifenovir and chloroquine diphosphate

umifenovir has been researched along with chloroquine diphosphate in 4 studies

Compound Research Comparison

Studies (umifenovir)	Trials (umifenovir)	Recent Studies (post-2010) (umifenovir)	Studies (chloroquine diphosphate)	Trials (chloroquine diphosphate)	Recent Studies (post-2010) (chloroquine diphosphate)
234	23	172	529	24	108

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	4 (100.00)	2.80

Authors

Authors	Studies
Wang, Y; Zhu, LQ	1
Amore, A; Bimonte, S; Cascella, M; Celentano, E; Crispo, A; Cuomo, A	1
Cai, C; Deng, Y; Hu, ZY; Huang, K; Huang, Y; Wang, X; Wang, Y; Xie, J; Xie, Y; Xu, D; Zang, J; Zhan, T; Zheng, F	1
Cai, L; Cao, Y; Fu, M; Guo, X; Hong, L; Yi, G; Ying, P; Zhang, Y	1

Reviews

2 review(s) available for umifenovir and chloroquine diphosphate

Article	Year
Pharmaceutical care recommendations for antiviral treatments in children with coronavirus disease 2019. World journal of pediatrics : WJP, 2020, Volume: 16, Issue:3 Topics: Adolescent; Age Factors; Antiviral Agents; Child; Child, Preschool; China; Chloroquine; Coronavirus Infections; COVID-19; Female; Humans; Indoles; Infant; Infant, Newborn; Interferon-alpha; Lopinavir; Male; Pandemics; Pharmaceutical Services; Pneumonia, Viral; Practice Guidelines as Topic; Prognosis; Ribavirin; Risk Assessment; Severe Acute Respiratory Syndrome; Treatment Outcome	2020
Potential Antiviral Drugs for SARS-Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research. In vivo (Athens, Greece), 2020, Volume: 34, Issue:3 Suppl Topics: Adenosine Monophosphate; Alanine; Animals; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; Drug Combinations; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Drugs, Investigational; Humans; Indoles; Lopinavir; Multicenter Studies as Topic; Neuraminidase; Pandemics; Pneumonia, Viral; Primates; Ribavirin; Ritonavir; SARS-CoV-2; Treatment Outcome	2020

Article

Year

Pharmaceutical care recommendations for antiviral treatments in children with coronavirus disease 2019.

World journal of pediatrics : WJP, 2020, Volume: 16, Issue:3

Topics: Adolescent; Age Factors; Antiviral Agents; Child; Child, Preschool; China; Chloroquine; Coronavirus Infections; COVID-19; Female; Humans; Indoles; Infant; Infant, Newborn; Interferon-alpha; Lopinavir; Male; Pandemics; Pharmaceutical Services; Pneumonia, Viral; Practice Guidelines as Topic; Prognosis; Ribavirin; Risk Assessment; Severe Acute Respiratory Syndrome; Treatment Outcome

2020

Potential Antiviral Drugs for SARS-Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research.

In vivo (Athens, Greece), 2020, Volume: 34, Issue:3 Suppl

Topics: Adenosine Monophosphate; Alanine; Animals; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; Drug Combinations; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Drugs, Investigational; Humans; Indoles; Lopinavir; Multicenter Studies as Topic; Neuraminidase; Pandemics; Pneumonia, Viral; Primates; Ribavirin; Ritonavir; SARS-CoV-2; Treatment Outcome

2020

Other Studies

2 other study(ies) available for umifenovir and chloroquine diphosphate

Article	Year
Treatment strategies of hospitalized patients with coronavirus disease-19. Aging, 2020, 06-17, Volume: 12, Issue:12 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Betacoronavirus; China; Chloroquine; Coronavirus Infections; COVID-19; Drug Combinations; Drugs, Chinese Herbal; Female; gamma-Globulins; Glucocorticoids; Hospitalization; Humans; Immunologic Factors; Indoles; Interferons; Lopinavir; Male; Middle Aged; Oxygen; Pandemics; Pneumonia, Viral; Respiration, Artificial; Retrospective Studies; Ritonavir; SARS-CoV-2	2020
Determining available strategies for prevention and therapy: Exploring COVID‑19 from the perspective of ACE2 (Review). International journal of molecular medicine, 2021, Volume: 47, Issue:4 Topics: Angiotensin-Converting Enzyme 2; Antiviral Agents; Cardiovascular Diseases; Chloroquine; COVID-19; Host-Pathogen Interactions; Humans; Indoles; Molecular Targeted Therapy; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization	2021

Article

Year

Treatment strategies of hospitalized patients with coronavirus disease-19.

Aging, 2020, 06-17, Volume: 12, Issue:12

Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Betacoronavirus; China; Chloroquine; Coronavirus Infections; COVID-19; Drug Combinations; Drugs, Chinese Herbal; Female; gamma-Globulins; Glucocorticoids; Hospitalization; Humans; Immunologic Factors; Indoles; Interferons; Lopinavir; Male; Middle Aged; Oxygen; Pandemics; Pneumonia, Viral; Respiration, Artificial; Retrospective Studies; Ritonavir; SARS-CoV-2

2020

Determining available strategies for prevention and therapy: Exploring COVID‑19 from the perspective of ACE2 (Review).

International journal of molecular medicine, 2021, Volume: 47, Issue:4

Topics: Angiotensin-Converting Enzyme 2; Antiviral Agents; Cardiovascular Diseases; Chloroquine; COVID-19; Host-Pathogen Interactions; Humans; Indoles; Molecular Targeted Therapy; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization

2021